Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat

Circulation

Volumn 95, Issue 7, 1997, Pages 1910-1917

  Wollert, Kai C ^b   Studer, Roland ^b   Doerfer, Kristin ^b   Schieffer, Elisabeth ^b   Holubarsch, Christian ^b   Just, Hanjörg ^b   Drexler, Helmut ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

bradykinin; collagen; hypertrophy; myocardial infarction

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; KININ; LISINOPRIL; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PROTEIN PRECURSOR; UNCLASSIFIED DRUG; ZD 7155;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENZYME ACTIVITY; ENZYME INHIBITION; HEART HYPERTROPHY; HEART INFARCTION; HEART MUSCLE CELL; HEART WEIGHT; HISTOLOGY; KALLIKREIN KININ SYSTEM; MALE; NONHUMAN; NORTHERN BLOTTING; ORAL DRUG ADMINISTRATION; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030948469     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.7.1910     Document Type: Article

References (67)

1. Weisman HF, Bush DE, Mannisi JA, Weisfeldt ML, Healy B. Cellular mechanisms of myocardial infarct expansion. Circulation. 1988;78:186-201.
2. Pfeffer JM. Progressive ventricular dilation in experimental myocardial infarction and its attenuation by angiotensin-converting enzyme inhibition. Am J Cardiol. 1991;68:17D-25D.
3. Olivetti G, Capasso JM, Meggs LG, Sonnenblick EH, Anversa P. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res. 1991;68:856-869.
4. Drexler H, Hänze J, Finckh M, Lu W, Just H, Lang RE. Atrial natriuretic peptide in a rat model of cardiac failure: atrial and ventricular mRNA, atrial content, plasma levels, and effect of volume loading. Circulation. 1989;79:620-633.
5. Michel JB, Lattion AL, Salzmann JL, de Lourdes Cerol M, Philippe M, Camilleri JP, Corvol P. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res. 1988;62:641-650.
6. Van Krimpen K, Smits JFM, Leutjens JPM, Debets JJM, Schoemaker RG, Struyker-Boudier HAJ, Bosman FT, Daemen MJAP. DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effect of captopril. J Mol Cell Cardiol. 1991;23:1245-1253.
7. Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Riede UN, Drexler H. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation. 1994;89:2273-2282.
8. Pfeffer JM, Fischer TA, Pfeffer MA. Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction. Annu Rev Physiol. 1995;57:805-826.
9. Yamagishi H, Kim S, Nishikimi T, Takeuchi K, Takeda T. Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats. J Mol Cell Cardiol. 1993;25: 1369-1380.
10. Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: critical role of the AT1 receptor subtype. Circ Res. 1993;73:413-423.
11. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol. 1994;26:809-820.
12. Ishida H, Scicli AG, Carretero OA. Contribution of various rat plasma peptidases to kinin hydrolysis. J Pharmacol Exp Ther. 1989; 251:817-820.
13. Baumgarten CR, Linz W, Kunkel G, Schölkens BA, Wiemer G. Ramiprilat increases bradykinin outflow from isolated hearts of rat. Br J Pharmacol. 1993;108:293-295.
14. Campbell DJ, Kladis A, Duncan AM. Bradykinin peptides in kidney, blood, and other tissues of the rat. Hypertension. 1993;21: 155-165.
15. Campbell DJ, Kladis A, Duncan AM. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension. 1994;23:439-449.
16. Minshall RD, Nakamura F, Becker RP, Rabito SF. Characterization of bradykinin B2 receptors in adult myocardium and neonatal rat cardiomyocytes. Circ Res. 1995;76:773-780.
17. Xiong W, Chen L, Woodley-Miller C, Simson JV, Chao J. Identification, purification and localization of tissue kallikrein in rat heart. Biochem J. 1990;267:639-646.
18. Nolly H, Carbini LA, Scicli G, Carretero OA, Scicli AG. A local kallikrein-kinin system is present in rat hearts. Hypertension. 1994; 23:919-923.
19. Linz W, Schölkens BA. A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril. Br J Pharmacol. 1992;105:771-772.
20. McDonald KM, Mock J, D'Aloia A, Parrish T, Hauer K, Francis G, Stillman A, Cohn JN. Bradykinin antagonism inhibits the antigrowth effect of converting enzyme inhibition in the dog myocardium after discrete transmural myocardial necrosis. Circulation. 1995;91:2043-2048.
21. MacLean D, Fishbein MC, Braunwald E, Maroko PR. Long-term preservation of ischemic myocardium after experimental coronary artery occlusion. J Clin Invest. 1978;61:541-551.
22. Wollert KC, Studer R, von Bülow B, Drexler H. Survival after myocardial infarction in the rat: role of tissue angiotensin-converting enzyme inhibition. Circulation. 1994;90:2457-2467.
23. Oldham AA, Allott CP, Major JS, Smith CFC, Ratcliffe AH, Edwards MP, Gibson KH, Masek BB, Pearce RJ, Wood R. Zeneca ZD7155: a novel, potent and orally-effective angiotensin II receptor antagonist. Br J Pharmacol. 1993;109:136P. Abstract.
24. Wirth K, Hock FJ, Albus U, Linz W, Alpermann HG, Anagnostopoulos H, Henke S, Breipohl G, König W, Knolle J, Schölkens BA. Hoe140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br J Pharmacol. 1991;102:774-777.
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
26. Seidman CE, Duby AD, Choi E, Graham RM, Haber E, Homey C, Smith JA, Seidman JG. The structure of rat preproatrial natriuretic factor as defined by a complementary DNA clone. Science. 1984; 225:324-326.
27. Chan YL, Gutell R, Noller HF, Wool IG. The nucleotide sequence of a rat 18s ribosomal ribonucleic acid gene and a proposal for the secondary structure of 18s ribosomal ribonucleic acid. J Biol Chem. 1984;259:224-230.
28. Studer R, Reinecke H, Müller B, Holtz J, Just H, Drexler H. Increased angiotensin-1 converting enzyme gene expression in the failing human heart: quantification by competitive RNA polymerase chain reaction. J Clin Invest. 1994;94:301-310.
29. Goetz RM, Morano I, Calovini T, Studer R, Holtz J. Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem Biophys Res Commun. 1994;205: 905-910.
30. Marsden PA, Schappert KT, Chen HS, Flowers M, Sundell CL, Wilcox JN, Lamas S, Michel T. Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett. 1992;307:287-293.
31. Sessa WC, Harrison JK, Barber CM, Zeng D, Durieux ME, D'Angelo DD, Lynch KR, Peach MJ. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem. 1992;267:15274-15276.
32. Junqueira LC, Bignolas G, Brentani RR. Red sirius staining plus polarizing microscopy: a specific method for collagen detection in tissue sections. Histochem J. 1979;79:445-447.
33. Karam R, Healy BP, Wicker P. Coronary reserve is depressed in postmyocardial infarction reactive cardiac hypertrophy. Circulation. 1990;81:238-246.
34. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of the rat right and left ventricles in experimental hypertension. Circulation. 1990;67:1355-1364.
35. Schieffer B, Wollert KC, Berchthold M, Saal K, Schieffer E, Hornig B, Riede UN, Drexler H. Development and prevention of skeletal muscle structural alterations after experimental myocardial infarction. Am J Physiol. 1995;269:H1507-H1513.
36. Holubarsch C, Holubarsch T, Jacob R, Medugorac I, Thiedemann KU. Passive elastic properties of myocardium in different models and stages of hypertrophy: a study comparing mechanical, chemical, and morphometric parameters. In: Alpert NR, ed. Perspectives in Cardiovascular Research. New York, NY: Raven Press; 1983;7: 323-336.
37. Cushman DW, Cheung HS. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol. 1971;20:1637-1648.
38. Anversa P, Beghi C, Kikkawa Y, Olivetti G. Myocardial infarction in rats: infarct size, myocyte hypertrophy and capillary growth. Circ Res. 1986;58:26-37.
39. Linz W, Schaper J, Wiemer G, Albus U, Schölkens BA. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats. Br J Pharmacol. 1992;107:970-975.
40. Keeley FW, Elmoselhi A, Leenen FHH. Enalapril suppresses normal accumulation of elastin and collagen in cardiovascular tissues of growing rats. Am J Physiol. 1992;262:H1013-H1021.
41. Katwa LC, Ratajska A, Cleutjens JPM, Sun Y, Zhou G, Lee SJ, Weber KT. Angiotensin converting enzyme and kininase-II-like activities in cultured valvular interstitial cells of the rat heart. Cardiovasc Res. 1995;29:57-64.
42. Zhou G, Tyagi SC, Weber KT. Bradykinin regulates collagen turnover in cardiac fibroblasts. Clin Res. 1993;41:630A. Abstract.
43. Burch RM, Axelrod J. Dissociation of bradykinin-induced prostaglandin formation from phosphatidylinositol turnover in Swiss 3T3 fibroblasts: evidence for G protein regulation of phospholipase A2. Proc Natl Acad Sci U S A. 1987;84:6374-6378.
44. D'Orléans-Juste P, de Nucci G, Vane JR. Kinins act on B1 or B2 receptors to release conjointly endothelium-derived relaxing factors and prostacyclins from bovine aortic cells. Br J Pharmacol. 1989;96: 920-926.
45. Momose N, Fukuo K, Morimoto S, Ogihara T. Captopril inhibits endothelin-1 secretion from endothelial cells through bradykinin. Hypertension. 1993;21:921-924.
46. Goldstein RH, Polgar P. The effect and interaction of bradykinin and prostaglandins on protein and collagen production by lung fibroblasts. J Biol Chem. 1982;257:8630-8633.
47. Fine A, Poliks CF, Donahue LP, Smith BD, Goldstein RH. The differential effect of prostaglandin E2 on transforming growth factor-β and insulin-induced collagen formation in lung fibroblasts. J Biol Chem. 1989;264:16988-16991.
48. Trachtman H, Futterweit S, Singhal P. Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells. Biochem Biophys Res Commun. 1995;207:120-125.
49. Kolpakov V, Gordon D, Kulik TJ. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ Res. 1995;76:305-309.
50. Guarda E, Katwa LC, Myers PR, Tyagi SC, Weber KT. Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc Res. 1993;27:2130-2134.
51. Weber KT, Sun Y, Guarda E. Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension. 1994; 23:869-877.
52. Wiemer G, Fink E, Korth P, Wohlfart P, Schölkens BA, Linz W. Blockade of Ang II (subtype AT1) receptors induces kinin and prostacyclin release from isolated perfused rat hearts. Hypertension. 1994;24:396. Abstract.
53. Kinoshita A, Urata H, Bumpus FM, Husain A. Measurement of angiotensin I converting enzyme inhibition in the heart. Circ Res. 1993;73:51-60.
54. Sun Y, Weber KT. Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovasc Res. 1994;28:1623-1628.
55. Gohlke P, Linz W, Schölkens BA, Kuwer I, Bartenbach S, Schnell A, Unger T. Angiotensin-converting enzyme inhibition improves cardiac function: role of bradykinin. Hypertension. 1994;23:411-418.
56. Scicli AG. Increases in cardiac kinins as a new mechanism to protect the heart. Hypertension. 1994;23:419-421.
57. Hashimoto K, Hamamoto H, Honda Y, Hirose M, Furukawa S, Kimura E. Changes in components of kinin system and hemodynamics in acute myocardial infarction. Am Heart J. 1978;95:619-626.
58. Matsuki T, Shoji T, Yoshida S, Kudoh Y, Motoe M, Inoue M, Nakata T, Hosada S, Shimamoto K, Yellon D, Iimura O. Sympathetically induced myocardial ischemia causes the heart to release plasma kinin. Cardiovasc Res. 1987;21:428-432.
59. Hartman JC, Wall TM, Hullinger TG, Shebuski RJ. Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140. J Cardiovasc Pharmacol. 1993;21: 996-1003.
60. Farhy RD, Carretero OA, Ho KL, Scicli AG. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res. 1993;72:1202-1210.
61. 1-adrenoreceptor blockade, converting enzyme inhibitor therapy, and angiotensin II subtype 1 receptor blockade on ventricular remodeling in the dog. Circulation. 1994;90:3034-3046.
62. Jugdutt BI, Khan MI, Jugdutt SJ, Blinston GE. Effect of enalapril on ventricular remodeling and function during healing after anterior myocardial infarction in the dog. Circulation. 1995;91: 802-812.
63. Hecker M, Pörsti I, Bara AT, Busse R. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level. Br J Pharmacol. 1994;111:238-244.
64. Hirsch AT, Talsness CE, Smith AD, Schunkert H, Ingelfinger JR, Dzau VJ. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure. Circulation. 1992;86:1566-1574.
65. Wiemer G, Schölkens BA, Busse R, Wagner A, Heitsch A, Linz W. The functional role of angiotensin II - subtype AT2 - receptors in endothelial cells and isolated ischemic rat hearts. Pharm Pharmacol Lett. 1993;3:24-27.
66. Goldberg MR, Tanaka W, Barchowsky A, Bradstreet TE, McCrea J, Lo MW, McWilliams EJ, Bjornsson TD. Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers. Hypertension. 1993;21:704-713.
67. Sun Y, Cleutjens JPM, Diaz-Arias AA, Weber KT. Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res. 1994;28:1423-1432.